FDA approves neratinib for metastatic HER2-positive breast cancer
The Food and Drug Administration (FDA) approved neratinib in combination with capecitabine for adult patients…
Browsing: neratinib
AACR 2018: Acquired HER2 mutations confer resistance to hormone therapy in ER positive MBC
Mutations in human epidermal growth factor receptor2 (HER2) were found to confer resistance to hormone…
Two groundbreaking studies reflect new paradigm in breast cancer research
In a new paradigm of breast cancer research, physicians are fast-tracking promising new experimental drugs…